229 related articles for article (PubMed ID: 27090942)
1. Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK's population-based Haematological Malignancy Research Network 2004-15.
Roman E; Smith A; Appleton S; Crouch S; Kelly R; Kinsey S; Cargo C; Patmore R
Cancer Epidemiol; 2016 Jun; 42():186-98. PubMed ID: 27090942
[TBL] [Abstract][Full Text] [Related]
2. Lymphoid blood cancers, incidence and survival 2005-2023: A report from the UK's Haematological Malignancy Research Network.
Lamb M; Painter D; Howell D; Barrans S; Cargo C; de Tute R; Tooze R; Burton C; Patmore R; Roman E; Smith A
Cancer Epidemiol; 2024 Feb; 88():102513. PubMed ID: 38160571
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network.
Smith A; Crouch S; Lax S; Li J; Painter D; Howell D; Patmore R; Jack A; Roman E
Br J Cancer; 2015 Apr; 112(9):1575-84. PubMed ID: 25867256
[TBL] [Abstract][Full Text] [Related]
4. Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).
Li J; Smith A; Crouch S; Oliver S; Roman E
Cancer Causes Control; 2016 Aug; 27(8):1019-26. PubMed ID: 27351920
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
6. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
[TBL] [Abstract][Full Text] [Related]
7. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study.
Sant M; Minicozzi P; Mounier M; Anderson LA; Brenner H; Holleczek B; Marcos-Gragera R; Maynadié M; Monnereau A; Osca-Gelis G; Visser O; De Angelis R;
Lancet Oncol; 2014 Aug; 15(9):931-42. PubMed ID: 25030467
[TBL] [Abstract][Full Text] [Related]
8. Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12.
Srour SA; Devesa SS; Morton LM; Check DP; Curtis RE; Linet MS; Dores GM
Br J Haematol; 2016 Aug; 174(3):382-96. PubMed ID: 27061824
[TBL] [Abstract][Full Text] [Related]
9. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
[TBL] [Abstract][Full Text] [Related]
10. Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia.
Edlin R; Connock M; Tubeuf S; Round J; Fry-Smith A; Hyde C; Greenheld W
Health Technol Assess; 2010 May; 14 Suppl 1():69-74. PubMed ID: 20507806
[TBL] [Abstract][Full Text] [Related]
11. Distribution pattern and prevalence of haematological cancers among adults in Abakaliki, South-Eastern Nigeria.
Ugwu NI; Okoye AE; Ugwu CN; Iyare FE; Edegbe FO; Ugwu GC; Chukwurah EF; Richard IC; John DO; Nnadozie UU; Nwokwu EU
Niger Postgrad Med J; 2021; 28(4):266-272. PubMed ID: 34850754
[TBL] [Abstract][Full Text] [Related]
12. Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Connor MP; Loren AW; Hexner EO; Martin ME; Gill SI; Luger SM; Mangan JK; Perl AE; McCurdy SR; Pratz KW; Timlin C; Freyer CW; Carulli A; Catania C; Smith J; Hollander L; Zebrowski AM; Stadtmauer EA; Porter DL; Frey NV
Transplant Cell Ther; 2023 Feb; 29(2):113-118. PubMed ID: 36336258
[TBL] [Abstract][Full Text] [Related]
13. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.
Park EH; Lee H; Won YJ; Ju HY; Oh CM; Ingabire C; Kong HJ; Park BK; Yoon JY; Eom HS; Lee E; Park HJ
Blood Res; 2015 Dec; 50(4):204-17. PubMed ID: 26770948
[TBL] [Abstract][Full Text] [Related]
14. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
15. Are myelodysplastic syndromes underdiagnosed in Poland? A report by the Polish Adult Leukaemia Group.
Drozd-Sokołowska JE; Mądry K; Waszczuk-Gajda A; Żółtak T; Sikorska A; Mital A; Wajs J; Semeńczuk G; Szmigielska-Kapłon A; Szczepańska M; Wasilewska E; Szwedyk P; Hołojda J; Wątek M; Stella-Hołowiecka B; Soroka-Wojtaszko M; Homenda W; Polak M; Guzicka-Kazimierska R; Porowska A; Wiktor-Jędrzejczak W; Dwilewicz-Trojaczek J
Eur J Haematol; 2017 Feb; 98(2):154-159. PubMed ID: 27699872
[TBL] [Abstract][Full Text] [Related]
16. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
Smith A; Howell D; Patmore R; Jack A; Roman E
Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
[TBL] [Abstract][Full Text] [Related]
17. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
[TBL] [Abstract][Full Text] [Related]
18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
Owattanapanich W; Herzig J; Jahn N; Panina E; Ruchutrakool T; Kungwankiattichai S; Issaragrisil S; Döhner H; Döhner K
Ann Hematol; 2021 Aug; 100(8):1983-1993. PubMed ID: 33839881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
